MX171572B - SUBSTANCE CONTAINING SPECIFIC ANTIBODY FROM EGGS AND METHOD OF PRODUCTION AND USE THEREOF - Google Patents

SUBSTANCE CONTAINING SPECIFIC ANTIBODY FROM EGGS AND METHOD OF PRODUCTION AND USE THEREOF

Info

Publication number
MX171572B
MX171572B MX499287A MX499287A MX171572B MX 171572 B MX171572 B MX 171572B MX 499287 A MX499287 A MX 499287A MX 499287 A MX499287 A MX 499287A MX 171572 B MX171572 B MX 171572B
Authority
MX
Mexico
Prior art keywords
specific antibody
antigen
hen
egg
substance containing
Prior art date
Application number
MX499287A
Other languages
Spanish (es)
Inventor
Hideo Tokoro
Original Assignee
Forvest Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61218859A external-priority patent/JPH0753669B2/en
Application filed by Forvest Ltd filed Critical Forvest Ltd
Publication of MX171572B publication Critical patent/MX171572B/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a un metodo para producir una composición farmaceutica inmunizante administrable oralmente para proteger a un mamífero de enfermedades infecciosas intestinales causadas por un antígeno patogénico, que comprende: inocular una gallina con el antígeno patogenico para inmunizarla contra dicho antígeno y producir un antigeno para inmunizarla contra dicho antígeno y producir un anticuerpo específico contra el antígeno dentro del cuerpo de la gallina; recoger un huevo puesto por la gallina despues de que el anticuerpo específico sea producido en el huevo; y recuperar toda la porción o una fracción del huevo total, yema o clara, del huevo que contiene el anticuerpo específico como una sustancia que contiene el anticuerpo específico, conteniendo dicha sustancia un anticuerpo específico que es activo contra el antígeno usado en la inmunización de la gallina.The present invention relates to a method of producing an orally administrable immunizing pharmaceutical composition for protecting a mammal from intestinal infectious diseases caused by a pathogenic antigen, comprising: inoculating a hen with the pathogenic antigen to immunize it against said antigen and producing an antigen to immunize her against said antigen and produce a specific antibody against the antigen within the body of the hen; collecting an egg laid by the hen after the specific antibody is produced in the egg; and recovering the entire portion or a fraction of the total egg, yolk or white, of the egg containing the specific antibody as a substance containing the specific antibody, said substance containing a specific antibody that is active against the antigen used in the immunization of the hen.

MX499287A 1986-09-17 1987-01-21 SUBSTANCE CONTAINING SPECIFIC ANTIBODY FROM EGGS AND METHOD OF PRODUCTION AND USE THEREOF MX171572B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61218859A JPH0753669B2 (en) 1985-11-25 1986-09-17 Material containing specific antibody from hen's egg, production method and use thereof

Publications (1)

Publication Number Publication Date
MX171572B true MX171572B (en) 1993-11-08

Family

ID=16726437

Family Applications (1)

Application Number Title Priority Date Filing Date
MX499287A MX171572B (en) 1986-09-17 1987-01-21 SUBSTANCE CONTAINING SPECIFIC ANTIBODY FROM EGGS AND METHOD OF PRODUCTION AND USE THEREOF

Country Status (1)

Country Link
MX (1) MX171572B (en)

Similar Documents

Publication Publication Date Title
ES2052496T3 (en) SUBSTANCE CONTAINING SPECIFIC ANTIBODY OBTAINED FROM EGGS AND METHOD FOR ITS PRODUCTION AND USE.
Clark et al. Immune response of infants and children to low-passage bovine rotavirus (strain WC3)
Jarrett et al. Potentiation of rat reaginic (IgE) antibody of helminth infection: Simultaneous potentiation of separate reagins
Kasel et al. Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine
FI860015A (en) Method for the preparation of a vaccine against diseases caused by bacteria infecting mammalian tissues carrying piluses
ATE211767T1 (en) ATTENUATION OF AN IMMUNODOMINATING EPITOPE OF AN ANTIGEN FOR USE FOR PLANT, ANIMAL AND HUMAN VACCINES AND IMMUNOTHERAPIES
DK0461177T3 (en) Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
Webster et al. A new avian influenza virus from feral birds in the USSR: recombination in nature?
Magill et al. Studies with human influenza virus cultivated in artificial medium
Hilleman A forward look at viral vaccines: with special reference to a new immunologic adjuvant
Schmidt et al. Immunodiffusion reactions with rubella antigens
Mayr et al. Persistent infections caused by Borna virus
MX171572B (en) SUBSTANCE CONTAINING SPECIFIC ANTIBODY FROM EGGS AND METHOD OF PRODUCTION AND USE THEREOF
Smorodincev The efficacy of live influenza vaccines
DE69130206T2 (en) REASSORTED ROTAVIRUS VACCINE
Tomasi The concept of local immunity and the secretory system
EP3362092A1 (en) Manufacture and use of personalized hyperimmune egg in psoriasis treatment
Kerman et al. Altered response to pneumococcal polysaccharide in offspring of immunologically paralyzed mice
Weil et al. The type-specificity of immune protection against Shigella paradysenteriae (Flexner)
Petroff Immunity in tuberculosis: Vaccination with living virulent, avirulent and dead tubercle bacilli
Menšík et al. Development of Antibody Response to Swine Influenza Virus in Pigs: I. The Influence of Experimental Infection of Pregnant Sows on Serum Antibody Production by their Progeny during Postnatal Development
US2998349A (en) Vaccine against avian respiratory infection
RU2332232C1 (en) Method of preventive poliomyelitis vaccination in far north
PITTMAN et al. VI. Cholera Vaccines
US2112507A (en) Process of producing vaccine lymph